Clinical trial Recruiting at 1 site Observational Ages 21 to 75

Kuwait Adult Diabetes Epidemiological Multidisciplinary Program

Official title: Kuwait Adult Diabetes Epidemiological Multidisciplinary (KADEM) Program

Run by Dasman Diabetes Institute · NCT06115876 · Data updated 2026-11-12

This study looks at people in Kuwait to see how obesity and genetics affect the risk of developing prediabetes and diabetes, hoping to find better ways to prevent these conditions.

Quick facts

Study typeObservational
Ages21 Years to 75 Years
SexAll
Enrollment2000 (estimated)
SponsorDasman Diabetes Institute
Academic / other
Locations1 site (Kuwait City)
StatusRecruiting
StartedMay 23, 2022
Main results expectedMay 23, 2027
Study endsMay 23, 2027
Registry record updatedNovember 3, 2023
Trial IDNCT06115876 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals who participated in the original KDEP study, as well as those diagnosed with prediabetes or Type 2 diabetes.

Probably not a fit

Patients who are unwilling to sign the consent form or are pregnant will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This program aims to follow up on participants from the Kuwait Diabetes Epidemiology Program to identify risk factors for prediabetes and diabetes in the Kuwaiti population. It focuses on understanding the impact of obesity and genetic factors on the onset of diabetes and related metabolic disorders. By collecting longitudinal data, the study seeks to enhance the understanding of diabetes progression and inform prevention strategies. The research will utilize a multidisciplinary approach, incorporating genetics, biochemistry, and epidemiology.

Why it matters

Potential benefit: If successful, this program could lead to improved prevention and management strategies for diabetes and related conditions in the Kuwaiti population.

How similar studies have gone: Other studies in similar populations have shown success in identifying risk factors for diabetes, but this program aims to provide a more comprehensive longitudinal perspective.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

People who participated in the original KDEP study. People with prediabetes. Type 2 Diabetes patients.

Exclusion Criteria:

People are unwilling to sign the consent form. Pregnant women.

Where it's running

  • Dasman Diabetes Institute
    Kuwait City, Kuwait
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.